Oct 9, 2023 | Diabetes Business, Featured, Research News, Technology Updates
What Is Insulin Resistance and How Do You Know if You Have It? by Knvul Sheikh for NYTimes.com, 3 October 2023. Insulin is a hormone secreted by the pancreas that is crucial for converting food into energy, or storing that energy for later. When your blood...
Jul 5, 2023 | Advocacy, Featured, Research News, Technology Updates
FDA approves novel pancreatic islet cell therapy for adults with type 1 diabetes by Jill Rollet for Healio.com/endocrinology, 29 June 2023. The FDA approved an allogenic pancreatic islet cellular therapy for adults with type 1 diabetes who struggled to achieve their...
Dec 9, 2022 | Featured, Research News, Technology Updates
Dexcom G7 CGM System Receives FDA Clearance posted on EndocrinologyNetwork.com, 8 December 2022. Dexcom has announced their Dexcom G7 Continuous Glucose Monitoring (CGM) system has received clearance from the US Food and Drug Administration for people with all types...
Oct 17, 2022 | Advocacy, Featured, Research News, Technology Updates
Dexcom Announces Global Rollout of G7, as reported by Andrew Briskin for diaTribe.org, 10 October 2022. Dexcom, one of the leading manufacturers of CGM, announced on Oct. 4 that its latest product, the Dexcom G7, is now available for people with diabetes, ages 2...
May 16, 2022 | Featured, Research News, Technology Updates
Dexcom Chief Tech Officer Leach discusses G7’s European launch and FDA review, expanding Dexcom One as written by Ricky Zipp for MedTechDrive.com, 10 May 2022. Dexcom’s newest continuous glucose monitoring system, called G7, was released last quarter...